{"entity":{"type":"insider","cik":"0002038768","url":"/insider/0002038768","json_url":"/insider/0002038768.json","name":"Friberg Gregory R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":2,"n_filings":2,"first":"2026-02-26","last":"2026-05-11","span_basis":"filed_date"},"name_variants":[{"name":"Friberg Gregory R","source":"filing","n_filings":2,"first_seen":"2026-02-26","last_seen":"2026-05-11"}],"transactions":[{"id":5896369,"accession":"0001628280-26-033639","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-033639","line_url":"/filing/0001628280-26-033639#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0002038768","owner_name":"Friberg Gregory R","owner_display_name":"Friberg Gregory R","owner_url":"/insider/0002038768","role":"Officer (EVP, Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3281.0,"shares_display":"3,281","price_per_share":53.85,"price_display":"53.85","price_state":"stated","total_value":176681.85,"total_display":"176,681.85","total_whole":"176,682","shares_owned_after":51818.0,"shares_owned_after_display":"51,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-07","filed_date":"2026-05-11","scope":"insider"},{"id":6077080,"accession":"0001628280-26-012539","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-012539","line_url":"/filing/0001628280-26-012539#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0002038768","owner_name":"Friberg Gregory R","owner_display_name":"Friberg Gregory R","owner_url":"/insider/0002038768","role":"Officer (EVP, Chief R&D Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief R&D Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief R&D Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6326.0,"shares_display":"6,326","price_per_share":60.3758,"price_display":"60.38","price_state":"stated","total_value":381937.3108,"total_display":"381,937.31","total_whole":"381,937","shares_owned_after":37578.0,"shares_owned_after_display":"37,578","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-26","filed_date":"2026-02-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":2,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":2},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001048477","name":"BIOMARIN PHARMACEUTICAL INC","url":"/issuer/0001048477","role":"Officer (EVP, Chief R&D Officer)","n_filings":2,"first_seen":"2026-02-26","last_seen":"2026-05-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002038768","retrieved_at":"2026-08-22T20:01:21+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}